<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>L‑Citrulline for AFib – NO Pathway, Evidence, Dosage</title>
  <meta name="description" content="L‑citrulline and atrial fibrillation: nitric‑oxide pathway, vascular effects, metabolomic associations, suggested dosages and safety.">
  <link rel="canonical" href="https://benkogerrie.github.io/atrial-fibrillation-org/citrulline.html">
  <meta property="og:title" content="L‑Citrulline for AFib – NO Pathway, Evidence, Dosage">
  <meta property="og:description" content="Overview of L‑citrulline in AFib: NO bioavailability, endothelial function, human associations and research links.">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://benkogerrie.github.io/atrial-fibrillation-org/citrulline.html">
  <meta property="og:image" content="https://benkogerrie.github.io/atrial-fibrillation-org/logo.svg">
  <link rel="stylesheet" href="styles.css">
</head>
<body>
  <header class="header">
    <nav class="nav">
      <div class="nav-container">
        <div class="nav-logo">
          <a href="index.html#home" class="nav-link"><img src="logo.svg" alt="Atrial Fibrillation Logo" class="logo"></a>
        </div>
        <ul class="nav-menu">
          <li><a href="index.html#home" class="nav-link">Home</a></li>
          <li><a href="index.html#supplements" class="nav-link">Supplements</a></li>
          <li><a href="index.html#research" class="nav-link">Research</a></li>
          <li><a href="index.html#contact" class="nav-link">Contact</a></li>
        </ul>
      </div>
    </nav>
  </header>

  <main style="margin-top:80px;">
    <section class="container" style="padding-top:2rem; padding-bottom:2rem;">
      <div class="section-header">
        <h1>L‑Citrulline and Atrial Fibrillation</h1>
        <p>NO pathway support, evidence and practical considerations</p>
      </div>

      <div class="about-card" style="text-align:left;">
        <h2>Why L‑citrulline?</h2>
        <p>L‑citrulline is a precursor to L‑arginine and increases nitric‑oxide (NO) bioavailability. It may improve endothelial function and vascular tone—mechanisms relevant to AFib triggers and substrate.</p>
      </div>

      <div class="about-grid" style="margin-top:1.5rem;">
        <div class="about-card" style="text-align:left;">
          <h3>Mechanisms</h3>
          <ul style="margin-left:1.25rem;">
            <li>Raises plasma arginine and NO availability.</li>
            <li>Improves endothelial function and blood flow.</li>
            <li>Potential indirect effects on atrial substrate via vascular health.</li>
          </ul>
        </div>
        <div class="about-card" style="text-align:left;">
          <h3>Evidence (Summary)</h3>
          <ul style="margin-left:1.25rem;">
            <li>Systematic reviews show improved NO/vascular function; direct AF outcomes are limited.</li>
            <li>Human metabolomics show citrulline increases after successful ablation (association).</li>
            <li>See Research section for citations and related NO donor trial.</li>
          </ul>
        </div>
      </div>

      <div class="about-card" style="text-align:left; margin-top:1.5rem;">
        <h3>Suggested dosing (informational)</h3>
        <p>Common supplemental ranges: 3–6 g/day, often split doses. May interact with antihypertensives or PDE‑5 inhibitors—consult your physician.</p>
      </div>

      <div class="about-card" style="text-align:left; margin-top:1.5rem;">
        <h3>Research Links</h3>
        <p>Browse the curated studies in the <a href="index.html#research">Research section</a>.</p>
      </div>

      <div class="disclaimer" style="margin-top:1.5rem;">
        <p><strong>Medical disclaimer:</strong> This page is educational and not medical advice. Always consult your physician before using supplements.</p>
      </div>
    </section>
  </main>

  <footer class="footer">
    <div class="container">
      <div class="footer-bottom">
        <p>&copy; atrial-fibrillation.org. All rights reserved.</p>
      </div>
    </div>
  </footer>
</body>
</html>
